Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Pharma
Roche's high-dose version of Ocrevus flunks phase 3 trial
Roche had high hopes for its high dose version of multiple sclerosis powerhouse Ocrevus, but a trial of the new formulation has come up short.
Kevin Dunleavy
Apr 2, 2025 3:26pm
MS meds send CNS market toward strongest growth in years
Mar 26, 2025 10:48am
Selma Blair joins EMD Serono campaign for MS drug Mavenclad
Feb 20, 2025 1:11pm
Biogen places chips behind 4 new drugs as MS competition mounts
Feb 12, 2025 11:35am
Teva's Copaxone gets boxed warning for anaphylaxis risk
Jan 23, 2025 7:52am
Teva hit with €463M fine over Copaxone misconduct claims in EU
Oct 31, 2024 10:45am
